Hospitalized patients got a median (IQR) of 6 (4C7) days from sign starting point to antibody administration, weighed against 4 (2C6.25) times in the non-hospitalized cohort (Desk 2). of 4 times. One patient needed SMAP-2 (DT-1154) intensive care device admission … Continue reading Hospitalized patients got a median (IQR) of 6 (4C7) days from sign starting point to antibody administration, weighed against 4 (2C6